FTC Judge Rejects Challenge To Illumina's $8B Grail Deal
A Federal Trade Commission in-house judge has rejected the agency's challenge to Illumina's $8 billion reacquisition of cancer testing outfit Grail, Illumina said Thursday, ending an important chapter in the fight...To view the full article, register now.
Already a subscriber? Click here to view full article